PATHWAY GENOMICS CORPORATION – Trademark Portfolio
Entity Type: 03
PATHWAY GENOMICS CORPORATION holds 62 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 50 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 9 Nice Classification classes. The owner is based in SAN DIEGO, CA.
4045 SORRENTO VALLEY ROAD
SAN DIEGO, CA 92121
Showing of trademarks Trademarks
Trademark Classifications
PATHWAY GENOMICS CORPORATION's trademark portfolio spans 9 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Legal services; security services for the protection of property and individuals
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does PATHWAY GENOMICS CORPORATION have?
PATHWAY GENOMICS CORPORATION has 62 U.S. trademarks filed with the USPTO.
What trademark classes does PATHWAY GENOMICS CORPORATION file in?
PATHWAY GENOMICS CORPORATION files trademarks across 9 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 45 (Legal & Security Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What is PATHWAY GENOMICS CORPORATION's trademark registration success rate?
PATHWAY GENOMICS CORPORATION has a 0% trademark registration rate, with 0 out of 62 resolved applications resulting in successful registration. Currently, 0 applications are pending review.